Job openings for Pharmacists (98 posts) under Directorate of Health Services
Directorate of Health Services is commited to provide preventive, promotive, curative,and quality health services at an affordable price to the people of Assam. Directorate of Health Services (DHS) has an important role in the provision and administration of health services and in order to raise the quality, extend accountability and deliver the services fairly, effectively and courteously.
In continuation of this department’s earlier advertisement published vide No. HSE/143/2017/14595, dated 14"' Dec’ 2017, in the newspapers, inviting applications from intending candidates for Newly created Model Hospitals in the State for filling up of 34 number of posts for Pharmacists in different Districts under the Directorate of Health Services, Assam, it is further notified that additional 64 posts in different Districts of Assam under similar/ different categories have become available.(ADDENDUM)
The United States Pharmacopeia (USP) is a non–governmental, official public standards–setting authority for prescription and over–the–counter medicines and other healthcare products manufactured or sold in the United States. USP also sets widely recognized standards for food ingredients and dietary supplements. USP sets standards for the quality, purity, strength, and consistency of these products–critical to the public health. USP's standards are recognized and used in more than 130 countries around the globe. These standards have helped to ensure public health throughout the world for close to 200 years.
The Mumbai University Institute of Chemical Technology, known earlier as UDCT is the most outstanding Institute of the University of Mumbai. This prestigious institute is a jewel in the crown of the University of Mumbai. It was founded on 4th August 1934 and was recently awarded the status of the Institute on 26th January 2002 and renamed MUICT. It enjoys a unique and prominent place amongst the premier institutes that are engaged in education, training and research in the field of Chemical Engineering, Chemical Technology and Pharmacy in India. Located in central Mumbai over a lush green campus of 16 acres, the MUICT has a built-up area of 33000 m2 including classrooms, laboratories and hostels.
This is a question we’ve asked ourselves over and over. It’s how we at Medtronic have made hearts beat stronger and longer. It’s how we’ve pushed the limits of what technology can do in and for the body. It’s how we will continue to alleviate pain, restore health and extend life. Rising costs, an aging population, and the burden of chronic disease impact us all. And no single entity in the healthcare system can solve these challenges alone. That’s why we’re stepping forward. That’s why we’re prepared to put the full power of our technologies, services, resources — and our people — to work with new partners, in new ways, to usher in a new era in healthcare.
The Rajiv Gandhi Centre for Biotechnology (RGCB) is a growing phenomenon. Located in Thiruvananthapuram, the capital city of Kerala, RGCB began in 1990 amongst humble surroundings as a small charitable society called the Centre for Development of Education, Science and Technology (C-DEST). In 1991, recognizing its potential, the C-DEST was made a “Grant-in-Aid” institute of the Government of Kerala and renamed as Rajiv Gandhi Centre for Development of Education, Science and Technology (RGC-DEST), becoming the first institute in the country to be named after Sri Rajiv Gandhi, the young illustrious and visionary former Prime Minster of India.
Covance, a $15 billion Fortune 500 company, with operations in over 97 countries, has led the way in improving patient outcomes through visionary data sciences over the last five decades. We have supported 100% of the top 50 drugs in the market and all the oncology medicines approved in 2016. Our team of over 57,000 across the globe is committed to advancing healthcare and bringing new medicines to market sooner. Our unique perspectives, built from decades of scientific expertise and precision delivery, help our clients identify new approaches and anticipate tomorrow’s challenges as they evolve. Driven by a passion for excellence and a relentless commitment to quality, we unlock opportunities that advance innovation and deliver the promise of a healthier world. Together, with our large pharmaceutical and emerging biotech clients, Covance transforms today's health care challenges into tomorrow's solutions.
MSD is a global health care leader with a diversified portfolio of prescription medicines, vaccines and animal health products. Today, we are building a new kind of healthcare company – one that is ready to help create a healthier future for all of us. Our ability to excel depends on the integrity, knowledge, imagination, skill, diversity and teamwork of an individual like you. To this end, we strive to create an environment of mutual respect, encouragement and teamwork. As part of our global team, you’ll have the opportunity to collaborate with talented and dedicated colleagues while developing and expanding your career.
Department of Science & Technology (DST) was established in May 1971, with the objective of promoting new areas of Science & Technology and to play the role of a nodal department for organising, coordinating and promoting S&T activities in the country. The Department has major responsibilities for specific projects and programmes like Formulation of policies relating to Science and Technology, Matters relating to the Scientific Advisory Committee of the Cabinet (SACC) and etc.
Indian Institute of Chemical Technology, Hyderabad is a premier R&D Institute 
Panacea Biotec is a leading research based Health Management Company. We are engaged in research, development, manufacture & marketing of Vaccines, Bio-Pharmaceuticals and Pharmaceuticals (Rx & OTC) of international quality and Health Services. All Panacea Biotec plants are accredited by international agencies and they follow current Good Manufacturing Practices, as per WHO guidelines.Panacea Drugs Pvt. Ltd. was set up in the year 1984, with a commitment to make novel and innovative medicines affordable to the masses a dream of healthy India, and got listed in 1995 as Panacea Biotec Ltd. 
National Institute of Biologicals an autonomous Institution under the Ministry of Health & Family Welfare (MOHFW)-Government of India, was set up in January, 1992 to act as the national control laboratory for assuring the availability of high standard and good quality biological products for consumption in India and for exports. It was set up as a society (vide No. S-22590) under the Societies Registration Act 1860. laid down in Bye-Laws of the institute, for quality control of indigenously produced and imported biological products. Initial financial assistance in setting up the institute was provided by USAID and OECF - Japan.
The Public Health Foundation of India (PHFI) is a not-for-profit public private initiative that has collaboratively evolved through consultations with multiple constituencies including Indian and international academia, state and central governments, multi & bi-lateral agencies and civil society groups. PHFI is a response to redress the limited institutional capacity in India for strengthening training, research and policy development in the area of Public Health. The PHFI focuses on broad dimensions of public health that encompass promotive, preventive and therapeutic services, many of which are frequently lost sight of in policy planning as well as in popular understanding.
This is a question we’ve asked ourselves over and over. It’s how we at Medtronic have made hearts beat stronger and longer. It’s how we’ve pushed the limits of what technology can do in and for the body. It’s how we will continue to alleviate pain, restore health and extend life. Rising costs, an aging population, and the burden of chronic disease impact us all. And no single entity in the healthcare system can solve these challenges alone. That’s why we’re stepping forward. That’s why we’re prepared to put the full power of our technologies, services, resources — and our people — to work with new partners, in new ways, to usher in a new era in healthcare.
